Cargando…

Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models

Despite tremendous advances in neonatal intensive care over the past 20 years, prematurity carries a high burden of neurological morbidity lasting lifelong. The term encephalopathy of prematurity (EoP) coined by Volpe in 2009 encompasses all aspects of the now known effects of prematurity on the imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Truttmann, Anita C., Ginet, Vanessa, Puyal, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039819/
https://www.ncbi.nlm.nih.gov/pubmed/32133356
http://dx.doi.org/10.3389/fcell.2020.00027
_version_ 1783500857541656576
author Truttmann, Anita C.
Ginet, Vanessa
Puyal, Julien
author_facet Truttmann, Anita C.
Ginet, Vanessa
Puyal, Julien
author_sort Truttmann, Anita C.
collection PubMed
description Despite tremendous advances in neonatal intensive care over the past 20 years, prematurity carries a high burden of neurological morbidity lasting lifelong. The term encephalopathy of prematurity (EoP) coined by Volpe in 2009 encompasses all aspects of the now known effects of prematurity on the immature brain, including altered and disturbed development as well as specific lesional hallmarks. Understanding the way cells are damaged is crucial to design brain protective strategies, and in this purpose, preclinical models largely contribute to improve the comprehension of the cell death mechanisms. While neuronal cell death has been deeply investigated and characterized in (hypoxic–ischemic) encephalopathy of the newborn at term, little is known about the types of cell death occurring in preterm brain injury. Three main different morphological cell death types are observed in the immature brain, specifically in models of hypoxic–ischemic encephalopathy, namely, necrotic, apoptotic, and autophagic cell death. Features of all three types may be present in the same dying neuron. In preterm brain injury, description of cell death types is sparse, and cell loss primarily concerns immature oligodendrocytes and, infrequently, neurons. In the present review, we first shortly discuss the different main severe preterm brain injury conditions that have been reported to involve cell death, including periventricular leucomalacia (PVL), diffuse white matter injury (dWMI), and intraventricular hemorrhages, as well as potentially harmful iatrogenic conditions linked to premature birth (anesthesia and caffeine therapy). Then, we present an overview of current evidence concerning cell death in both clinical human tissue data and preclinical models by focusing on studies investigating the presence of cell death allowing discriminating between the types of cell death involved. We conclude that, to improve brain protective strategies, not only apoptosis but also other cell death (such as regulated necrotic and autophagic) pathways now need to be investigated together in order to consider all cell death mechanisms involved in the pathogenesis of preterm brain damage.
format Online
Article
Text
id pubmed-7039819
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70398192020-03-04 Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models Truttmann, Anita C. Ginet, Vanessa Puyal, Julien Front Cell Dev Biol Cell and Developmental Biology Despite tremendous advances in neonatal intensive care over the past 20 years, prematurity carries a high burden of neurological morbidity lasting lifelong. The term encephalopathy of prematurity (EoP) coined by Volpe in 2009 encompasses all aspects of the now known effects of prematurity on the immature brain, including altered and disturbed development as well as specific lesional hallmarks. Understanding the way cells are damaged is crucial to design brain protective strategies, and in this purpose, preclinical models largely contribute to improve the comprehension of the cell death mechanisms. While neuronal cell death has been deeply investigated and characterized in (hypoxic–ischemic) encephalopathy of the newborn at term, little is known about the types of cell death occurring in preterm brain injury. Three main different morphological cell death types are observed in the immature brain, specifically in models of hypoxic–ischemic encephalopathy, namely, necrotic, apoptotic, and autophagic cell death. Features of all three types may be present in the same dying neuron. In preterm brain injury, description of cell death types is sparse, and cell loss primarily concerns immature oligodendrocytes and, infrequently, neurons. In the present review, we first shortly discuss the different main severe preterm brain injury conditions that have been reported to involve cell death, including periventricular leucomalacia (PVL), diffuse white matter injury (dWMI), and intraventricular hemorrhages, as well as potentially harmful iatrogenic conditions linked to premature birth (anesthesia and caffeine therapy). Then, we present an overview of current evidence concerning cell death in both clinical human tissue data and preclinical models by focusing on studies investigating the presence of cell death allowing discriminating between the types of cell death involved. We conclude that, to improve brain protective strategies, not only apoptosis but also other cell death (such as regulated necrotic and autophagic) pathways now need to be investigated together in order to consider all cell death mechanisms involved in the pathogenesis of preterm brain damage. Frontiers Media S.A. 2020-02-18 /pmc/articles/PMC7039819/ /pubmed/32133356 http://dx.doi.org/10.3389/fcell.2020.00027 Text en Copyright © 2020 Truttmann, Ginet and Puyal. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Truttmann, Anita C.
Ginet, Vanessa
Puyal, Julien
Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
title Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
title_full Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
title_fullStr Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
title_full_unstemmed Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
title_short Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
title_sort current evidence on cell death in preterm brain injury in human and preclinical models
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039819/
https://www.ncbi.nlm.nih.gov/pubmed/32133356
http://dx.doi.org/10.3389/fcell.2020.00027
work_keys_str_mv AT truttmannanitac currentevidenceoncelldeathinpretermbraininjuryinhumanandpreclinicalmodels
AT ginetvanessa currentevidenceoncelldeathinpretermbraininjuryinhumanandpreclinicalmodels
AT puyaljulien currentevidenceoncelldeathinpretermbraininjuryinhumanandpreclinicalmodels